Phase Ia trial of ORMD 0802 in healthy volunteers.

Trial Profile

Phase Ia trial of ORMD 0802 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Feb 2009

At a glance

  • Drugs Insulin (Primary)
  • Indications Diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Oramed Pharmaceuticals
  • Most Recent Events

    • 04 Feb 2009 Status changed from not yet recruiting to completed, as reported in an Oramed media release.
    • 29 Oct 2008 New trial record.
    • 23 Oct 2008 Approval received from the South Africa Medicines Control Council to begin testing of newly developed insulin suppository in volunteers, according to an Oramed Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top